Trials / Recruiting
RecruitingNCT06512441
Vitamin B6 Aids in Treating Inflammatory Bowel Disease
Vitamin B6 Assists in the Treatment of Inflammatory Bowel Disease
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 220 (estimated)
- Sponsor
- Changhai Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Patients with IBD are randomized to oral administration of VitaminB6 and placebo based on the standard treatment, exploring whether VitaminB6 can increasee the clinical remission rateand improve the treatment effect of IBD patients.
Detailed description
Inflammatory bowel disease (IBD) is a group of chronic idiopathic inflammatory intestinal diseases, mainly including ulcerative colitis and Crohn's disease, with increasing incidence in China and worldwide. The disease currently lacks a cure, with many patients experiencing relapses and requiring surgery, and an increased risk of cancer. There is substantial evidence suggesting a close relationship between body vitamin B6 levels and IBD.Thus,we design this clinical trial that aims to explore whether VitaminB6 can increasee the clinical remission rateand improve the treatment effect.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitamin B6 Tablets | The experimental group was given a Vitamin B6 tablet(10mg/tablet)once a day for 3weeks, besides of the standard IBD treatment. |
| DRUG | Placebo | The control group was given a placebo tablet on the same type once a day for 3weeks, besides of the standard IBD treatment. |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2025-12-30
- Completion
- 2025-12-30
- First posted
- 2024-07-22
- Last updated
- 2024-07-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06512441. Inclusion in this directory is not an endorsement.